Literature DB >> 23330017

A rare case of adult hepatoblastoma with neuroendocrine differentiation misdiagnosed as neuroendocrine tumor.

Qingfu Zhang1, Jian Ming, Siyang Zhang, Dawei Guo, Xueshan Qiu.   

Abstract

Hepatoblastoma is the most common malignant liver tumor between the age of 6 months and 3 years, but it is extremely rare in adults. Only Forty-five cases of adult hepatoblastoma were reported up to now in the world. Hepatoblastoma exhibits a wide range of epithelial and mesenchymal lines differentiation, but neuroendocrine differentiation of this tumor has rare been reported in the literature. Here, we reported a case of primary giant hepatoblastoma (about 11.4*7.9*15.3 cm) with neuroendocrine differentiation of a 32-year-old woman, which was misdiagnosed as neuroendocrine tumor.

Entities:  

Keywords:  Hepatoblastoma; immunohistochemistry; neuroendocrine tumour (NET); squamous corpuscles

Mesh:

Year:  2013        PMID: 23330017      PMCID: PMC3544231     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  9 in total

1.  CD10 is a characteristic marker of tumours forming morules with biotin-rich, optically clear nuclei that occur in different organs.

Authors:  J Cameselle-Teijeiro; L Alberte-Lista; S Chiarelli; C Buriticá; L Gonçalves; R González-Cámpora; F F Nogales
Journal:  Histopathology       Date:  2007-12-13       Impact factor: 5.087

2.  An immunohistochemical study of morules in endometrioid lesions of the female genital tract: CD10 is a characteristic marker of morular metaplasia.

Authors:  Silvia Chiarelli; Catalina Buriticá; Piero Litta; Susana Ciani; Rosa Guarch; Francisco F Nogales
Journal:  Clin Cancer Res       Date:  2006-07-15       Impact factor: 12.531

3.  Pancreatoblastoma: a report from the European cooperative study group for paediatric rare tumours (EXPeRT).

Authors:  Ewa Bien; Jan Godzinski; Patrizia Dall'igna; Anne-Sophie Defachelles; Teresa Stachowicz-Stencel; Daniel Orbach; Gianni Bisogno; Giovanni Cecchetto; Steven Warmann; Verena Ellerkamp; Bernadette Brennan; Anna Balcerska; Malgorzata Rapala; Ines Brecht; Dominik Schneider; Andrea Ferrari
Journal:  Eur J Cancer       Date:  2011-06-21       Impact factor: 9.162

4.  Neuroendocrine differentiation in hepatoblastoma. An immunohistochemical investigation.

Authors:  P Ruck; D Harms; E Kaiserling
Journal:  Am J Surg Pathol       Date:  1990-09       Impact factor: 6.394

5.  Activation of beta-catenin in epithelial and mesenchymal hepatoblastomas.

Authors:  Y Wei; M Fabre; S Branchereau; F Gauthier; G Perilongo; M A Buendia
Journal:  Oncogene       Date:  2000-01-27       Impact factor: 9.867

6.  Teratoid hepatoblastoma with abundant neuroendocrine and squamous differentiation with extensive parenchymal metastasis.

Authors:  Raja Rabah
Journal:  Arch Pathol Lab Med       Date:  2012-08       Impact factor: 5.534

7.  Pancreatoblastoma: optically clear nuclei in squamoid corpuscles are rich in biotin.

Authors:  Y Tanaka; R Ijiri; S Yamanaka; K Kato; H Nishihira; T Nishi; K Misugi
Journal:  Mod Pathol       Date:  1998-10       Impact factor: 7.842

8.  Small cell undifferentiated variant of hepatoblastoma: adverse clinical and molecular features similar to rhabdoid tumors.

Authors:  Angela D Trobaugh-Lotrario; Gail E Tomlinson; Milton J Finegold; Lia Gore; James H Feusner
Journal:  Pediatr Blood Cancer       Date:  2009-03       Impact factor: 3.167

Review 9.  Liver cancer stem cells.

Authors:  Stewart Sell; Hyam L Leffert
Journal:  J Clin Oncol       Date:  2008-06-10       Impact factor: 44.544

  9 in total
  1 in total

1.  Effect of estradiol and bisphenol A on human hepatoblastoma cell viability and telomerase activity.

Authors:  B L Xu; Q Z Zhao; X Y Gao; G J Hou
Journal:  Braz J Med Biol Res       Date:  2015-09-18       Impact factor: 2.590

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.